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An obstetric fistula is an abnormal opening between the vagina and organs of pelvis.Each year, 
more than a quarter million women in Nigeria die in pregnancy and childbirth, of those that do not 
perish, suffer  from obstetric fistula (OF).OF caused by of obstructed labor, without timely medical 
intervention or Cesarean section. During this time, the soft tissues of the pelvis are compressed 
between the baby’s head and the mother’s pelvic bones. The lack of blood flow causes tissue to die, 
creating a hole between the mother’s vagina and organs of pelvis . 
Aim: to establish the disparity to development of OFin African countries with respect to their 
European counterparts. 
Aterials and methods: we did an epidemiological research in the Nigerian communities for 
the last 18 months (FMN, UNPF). Women between the ages of 15-40yrs were taken into account, in 
various communities sited in Nigeria and United nations population, from the time of pregnancy till 
postnatal period. 
Results: In Nigeria 1.5million women yearly going into childbirth resulting in 2,000,000 
accounted births yearly.10% of childbirth results in OF, 15.6 % cases treated immediatiatly,32% 
much later and wide majority not treated. According WHO is estimated that two million women suffer 
from OF globally. The cases of OF in Europe has drastically reduced since the beginning of 21 
century, with a thin population of  estimate of 2 in every 1000 births. 
Conclusion: Nigeria accounts for over 45% of world OF cases having a very high risk of 
prevalence, relating to poverty, early marriage, illiteracy, lack of quality maternal care, abortions, 
distance from health facility. European cases has become almost extinct due to improved health 
facility and high standard of living. 
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Objective: To present a basic clinical research based on current evidence about advanced 
treatment methods for vulvovaginal atrophy during menopause.And on principles of management of 
patients with vulvovaginal atrophy.Vulvovaginal atrophy (VVA) is a common and underreported 
condition associated with decreased estrogenization of the vaginal tissue. Symptoms include dryness, 
irritation, soreness, and dyspareunia with urinary frequency, urgency, and urge incontinence. It can 
occur at any time in a woman's life cycle, although more commonly in the postmenopausal phase, 
during which the prevalence is close to 50%. Clinical findings include the presence of pale and dry 
vulvovaginal mucosa with petechiae. Vaginal rugae disappear, and the cervix may become flush with 
the vaginal wall 
Materials and Methods: Ukrainian and foreign sources onprevalence, cytological method, pap 
smear, colposcopy method (before and after treatment), current management andtreatment of 
vulvovaginal atrophy were reviewed. We observed three groups of women, few premenopausal 
women with VVA, postmenopausal women and a control group. New treatment methods were 
identified and used on patients of different age groups,. For the treatment we used; hormonal therapy, 
laser therapy. 
Results: The present clinical guidelines give currentdata and information on aetiology, 
pathogenesis, clinical presentation, diagnosis, differential diagnosis and treatments of vulvovaginal 
atrophy in menopausal women.These treatment methods can be used for women who are diagnosed 
VVA. And after treatment the patients showed positive response.  
